✦ LIBER ✦

Prognostic factors for survival in Stage I epithelial ovarian carcinoma

✍ Scribed by Paul Sevelda; Norbert Vavra; Michael Schemper; Heinrich Salzer

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 353 KB
Volume: 65
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900515)65:10<2349::aid-cncr2820651031>3.0.co;2-#

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasminogen activator inhibitor-1 is an

Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients

✍ Setsuko K. Chambers; Christina M. Ivins; Maria L. Carcangiu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 103 KB 👁 1 views

High levels of plasminogen activator inhibitor-1 (PAI-1) in tissue extracts have been associated with poor prognosis in many epithelial cancers. Ovarian cancers contain a higher concentration of PAI-1 than benign ovarian tumors or normal ovaries. Reports, however, on the prognostic value of PAI-1 co

Preoperative serum level of inhibin A is

Preoperative serum level of inhibin A is an independent prognostic factor for the survival of postmenopausal women with epithelial ovarian carcinoma

✍ Antonio E. Frias Jr.; Honghze Li; Gary L. Keeney; Karl C. Podratz; Teresa K. Woo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Background: The aim of this study was to determine the prognostic significance of preoperative serum inhibin and activin levels in postmenopausal women with epithelial ovarian carcinoma (eoc) by correlating serum levels with disease parameters, including tumor stage and grade and patient age. #

Prognostic factors for survival in patie

Prognostic factors for survival in patients with brain metastases from renal cell carcinoma

✍ Stéphane Culine; Mohamed Bekradda; Andrew Kramar; Annie Rey; Bernard Escudier; J 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

The authors thank S. Ne ´grier, M.D., A. Ravaud, M.D., and G. Chvetzoff for providing the clinical charts of patients included in the external data set.

Prognostic factors in patients with hepa

Prognostic factors in patients with hepatocellular carcinoma attempts for the selection of patients with prolonged survival

✍ Pierre Attali; Sylvie Prod'homme; Gilles Pelletier; Laure Papoz; Olivier Ink; Ca 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB 👁 1 views

Conventional clinicopathologic prognosti

Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma : A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses

✍ Kenji Suzuki; Kanji Nagai; Junji Yoshida; Mitsuyo Nishimura; Kenro Takahashi; To 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## BACKGROUND. A number of prognostic factors have been reported for resected nonsmall cell lung carcinoma. None of them, however, has been reported to have greater prognostic impact than the pathologic TNM staging system. The authors evaluated 18 conventional clinicopathologic prognostic factors

Prognostic factors for survival in patie

Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy

✍ Maurizio Pompili; Gian Ludovico Rapaccini; Marcello Covino; Giulia Pignataro; Eu 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

## Background: The objective of this study was to identify clinical, biochemical, ultrasound, and/or pathologic parameters capable of predicting survival in a cohort of patients with well compensated cirrhosis and small hepatocellular carcinoma (hcc) who were treated with percutaneous ethanol injec